Purdue's $7.4B Ch. 11 Plan Jibes With New Release Paradigm

By Vince Sullivan · November 18, 2025, 5:26 PM EST

A New York bankruptcy judge gave a bench ruling Tuesday explaining his decision to confirm Purdue's $7.4 billion Chapter 11 plan, which transforms the pharmaceutical giant into a public benefit company,...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Bankruptcy Scorecard

Summary

Purdue Pharma filed for bankruptcy after reaching a settlement deal to end over 2,600 lawsuits that accused the maker of OxyContin of fueling a national opioid addiction crisis. In June 2024, the U.S. Supreme Court overturned Purdue's Chapter 11 plan finding non-debtor third parties, like Purdue's former owners the Sackler family, aren't authorized to receive non-consensual liability waivers under the U.S. Bankruptcy Code.

Case Number

19-bk-23649

Judge

Sean H. Lane

Venue

U.S. Bankruptcy Court for the Southern District of New York

Capital Structure

View Full Scorecard

Related Sections

Case Information

Case Title

Purdue Pharma L.P.

Case Number

7:19-bk-23649

Court

New York Southern

Nature of Suit

Date Filed

September 15, 2019

Recent Articles By Vince